Current News:
Bioject to Report Second Quarter 2010 Financial Results
Bioject’s Intradermal Needle-Free Delivery System Used in World Health Organization Clinical Trial in Oman with Poliovirus Vaccine
Bioject Announces Results of Intradermal Dose Sparing Influenza Study Conducted by the Centers for Disease Control and Prevention
Bioject Announces Results from US Navy Study for a Malaria Vaccine
Bioject Meets Final Development Milestone for Merial Ltd
Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine
Bioject Establishes Strategic Alliance with MPI Research
OTCBB: BJCT
2010 PROXY ANNUAL REPORT